Ernexa Therapeutics Inc.: 10-Q filed 2013-11-14
What Ernexa Therapeutics Inc. reported in its quarterly report filed 2013-11-14 (fiscal Q3 2013): 34 published measures, 92 facts as tagged in accession 0001019687-13-004331.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-14
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001019687-13-004331 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ernexa Therapeutics Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 11,649,000 | USD | |
| At 2012-12-31 | 12,656,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 4,407,000 | USD | |
| At 2012-12-31 | 4,762,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 7,242,000 | USD | |
| At 2012-12-31 | 7,894,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,168,000 | USD | |
| At 2012-12-31 | 2,721,000 | USD | |
| At 2012-09-30 | 2,405,000 | USD | |
| At 2011-12-31 | 1,374,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -234,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -702,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 54,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,624,000 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 1,069,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 994,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 521,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 966,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 145,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 2,033,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -1,743,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -2,027,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -112,440,000 | USD | |
| At 2012-12-31 | -111,730,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 71,202 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 71,043 | shares | 273 |
| 2012-07-01 to 2012-09-30 | 70,876 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 68,537 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 71,202 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 71,043 | shares | 273 |
| 2012-07-01 to 2012-09-30 | 71,373 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 68,537 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 0 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | -0.01 | USD/shares | 273 |
| 2012-07-01 to 2012-09-30 | 0 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -0.02 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 0 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | -0.01 | USD/shares | 273 |
| 2012-07-01 to 2012-09-30 | 0 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -0.02 | USD/shares | 274 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 16,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 22,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 26,000 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 3,227,000 | USD | |
| At 2012-12-31 | 3,783,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 87,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 163,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -236,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -717,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 99,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,541,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 3,893,000 | USD | |
| At 2012-12-31 | 4,229,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,905,000 | USD | |
| At 2012-12-31 | 3,388,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,222,000 | USD | |
| At 2012-12-31 | 1,265,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 259,000 | USD | |
| At 2012-12-31 | 579,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 5,762,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 17,891,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 5,951,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 19,672,000 | USD | 274 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 4,053,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 12,318,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 4,257,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 14,442,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 71,773 | shares | |
| At 2012-12-31 | 71,123 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 119,077,000 | USD | |
| At 2012-12-31 | 118,956,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 701,000 | USD | |
| At 2012-12-31 | 768,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 310,000 | USD | |
| At 2012-12-31 | 220,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 329,000 | USD | |
| At 2012-12-31 | 170,000 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 2,155,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 2,190,000 | USD | 274 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 104,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 319,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 93,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 280,000 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 5,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 31,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -23,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -57,000 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 15,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 35,000 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 73,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -437,000 | USD | 274 |
Inspect the source
- Entity
- Ernexa Therapeutics Inc. / CIK 0000748592
- Captured
- 2026-09-19T15:01:44.435Z
- SEC response SHA-256
c12754d65dfa742127976ccd7c75bc4379d46dc7b617393cfbda0b7763329d5c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000748592.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))